Approval · Notice of Compliance 11027 · 2010
METFORMIN: Notice of Compliance 11027
Issued February 10, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11027
- Date
- February 10, 2010
- Company
- Cobalt Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Oral antihyperglycemic agent
- Canadian reference product
- GLUCOPHAGE (Aventis Pharma Inc.)
Products in this notice
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- METFORMIN HYDROCHLORIDE 850 MG per TAB